Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

Background/Aims. Autonomic dysfunction (AD) after allogeneic stem cell transplant (SCT) is a rare occurrence and likely immune-mediated in etiology. There is limited literature on this topic and hence, we wish to briefly describe management of two cases at our institution and their outcomes. Methods...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Abhishek Mangaonkar, Hassan Al Khateeb, Narjust Duma, Erik K. St. Louis, Andrew McKeon, Mrinal Patnaik, William Hogan, Mark Litzow, Taxiarchis Kourelis
स्वरूप:	लेख
भाषा:	English
प्रकाशित:	Hindawi Limited 2017-01-01
श्रृंखला:	Case Reports in Hematology
ऑनलाइन पहुंच:	http://dx.doi.org/10.1155/2017/6803804

समान संसाधन

P1323: PREDICTION OF NON-RELAPSE MORTALITY BY EASIX AND HCT-CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT
द्वारा: A. Baranwal, और अन्य
प्रकाशित: (2022-06-01)

Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia
द्वारा: Naseema Gangat, और अन्य
प्रकाशित: (2022-06-01)

Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy
द्वारा: Naseema Gangat, और अन्य
प्रकाशित: (2023-03-01)

Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy
द्वारा: Isla M. Johnson, और अन्य
प्रकाशित: (2025-02-01)

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
द्वारा: Aref Al-Kali, और अन्य
प्रकाशित: (2023-04-01)

Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
द्वारा: Ayalew Tefferi, और अन्य
प्रकाशित: (2022-09-01)

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
द्वारा: Ayalew Tefferi, और अन्य
प्रकाशित: (2022-06-01)

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia
द्वारा: Naseema Gangat, और अन्य
प्रकाशित: (2023-08-01)

Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent
द्वारा: Nickolas Steinauer, और अन्य
प्रकाशित: (2024-03-01)

P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS
द्वारा: I. Johnson, और अन्य
प्रकाशित: (2022-06-01)

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
द्वारा: Vyas, P, और अन्य
प्रकाशित: (2015)

Allogeneic stem cell transplantation for acute myeloid leukemia
द्वारा: Jacopo Peccatori, और अन्य
प्रकाशित: (2010-06-01)

Allogeneic stem cell transplantation in acute myeloid leukemia
द्वारा: Natasha Ali, और अन्य
प्रकाशित: (2012-11-01)

Transplantation of allogenic bone marrow in chronic myeloid leukemias
द्वारा: L S Lyubimova, और अन्य
प्रकाशित: (2004-07-01)

The origins of the definition of complete remission in acute myeloid leukemia
द्वारा: Mark R. Litzow
प्रकाशित: (2025-02-01)

MYST3/CREBBP Rearranged Acute Myeloid Leukemia after Adjuvant Chemotherapy for Breast Cancer
द्वारा: Arjun Gupta, और अन्य
प्रकाशित: (2014-01-01)

The increasing complexity of the management of core-binding factor acute myeloid leukemia
द्वारा: Mark R. Litzow
प्रकाशित: (2020-06-01)

Mayo Clinic experience with 1123 adults with acute myeloid leukemia
द्वारा: Kebede H. Begna, और अन्य
प्रकाशित: (2021-03-01)

Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia
द्वारा: Gert J. Ossenkoppele, और अन्य
प्रकाशित: (2016-01-01)

Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia?
द्वारा: Arnold Ganser
प्रकाशित: (2021-10-01)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
द्वारा: Anagnostou T, और अन्य
प्रकाशित: (2018-04-01)

A novel Iowa–Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction
द्वारा: Kalyan Nadiminti, और अन्य
प्रकाशित: (2021-11-01)

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
द्वारा: Rami Basmaci, और अन्य
प्रकाशित: (2023-08-01)

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms
द्वारा: Mithun Vinod Shah, और अन्य
प्रकाशित: (2022-07-01)

OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH ACTIVE DISEASE IN ACUTE MYELOID LEUKEMIA
द्वारा: Mehmet Bakirtas, और अन्य
प्रकाशित: (2020-06-01)

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
द्वारा: Justin Loke, और अन्य
प्रकाशित: (2021-05-01)

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”
द्वारा: K. H. Begna, और अन्य
प्रकाशित: (2022-04-01)

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE
द्वारा: Bahga Katamesh, और अन्य
प्रकाशित: (2023-08-01)

How I diagnose and treat chronic myelomonocytic leukemia
द्वारा: Mrinal M. Patnaik
प्रकाशित: (2022-03-01)

FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(<i>DEK::NUP214</i>): The Mayo Clinic experience
द्वारा: Clifford M. Csizmar, और अन्य
प्रकाशित: (2024-06-01)

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
द्वारा: Muhamad Oum, और अन्य
प्रकाशित: (2023-08-01)

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
द्वारा: Andrew S. Artz, और अन्य
प्रकाशित: (2016-11-01)

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE
द्वारा: Amrutha Sai Mittapalli, और अन्य
प्रकाशित: (2023-08-01)

S263: CYTOPENIAS, AGE AND CAR-HEMATOTOX SCORE PREDICT THE DEVELOPMENT OF POST CAR T-CELL THERAPY-RELATED MYELOID NEOPLASMS
द्वारा: Mark Gurney, और अन्य
प्रकाशित: (2023-08-01)

UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTPATIENTS WITH ACUTE LEUKEMIAS AND CHRONIC MYELOID LEUKEMIA –6 YEARS EXPERIENCE
द्वारा: Jože Pretnar, और अन्य
प्रकाशित: (2008-04-01)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
द्वारा: Cindy M. Pabon, और अन्य
प्रकाशित: (2021-05-01)

IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?
द्वारा: Federica Sorà, और अन्य
प्रकाशित: (2021-10-01)

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
द्वारा: Håkon Reikvam, और अन्य
प्रकाशित: (2018-01-01)

Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
द्वारा: María Facenda-Lorenzo, और अन्य
प्रकाशित: (2016-01-01)

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
द्वारा: Shohei Mizuno, और अन्य
प्रकाशित: (2024-04-01)